New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

49

U.S. FDA declines to approve Y-mAbs’s pediatric cancer drug

The company was seeking approval of omburtamab to treat a rare form of nerve cancer in pediatric patients. The FDA’s decision follows a unanimous vote in October against the drug to treat neuroblastoma due to insufficient evidence that it improves overall survival.